Bring that pioneering spirit back! A 25-year perspective on the vascular stent.
作者信息
Palmaz Julio C
出版信息
Cardiovasc Intervent Radiol. 2007 Nov-Dec;30(6):1095-8. doi: 10.1007/s00270-007-9164-9. Epub 2007 Sep 6.
Abstract
摘要
相似文献
1
Bring that pioneering spirit back! A 25-year perspective on the vascular stent.
Cardiovasc Intervent Radiol. 2007 Nov-Dec;30(6):1095-8. doi: 10.1007/s00270-007-9164-9. Epub 2007 Sep 6.
2
Leaders in Cardiovascular Research: Peter Libby.
Cardiovasc Res. 2019 May 1;115(6):e61-e62. doi: 10.1093/cvr/cvz069.
3
Denisa Wagner.
Circ Res. 2018 Oct 12;123(9):1020-1023. doi: 10.1161/CIRCRESAHA.118.314091.
4
Ronglih Liao: Science as a Lifestyle.
Circ Res. 2016 May 13;118(10):1464-7. doi: 10.1161/CIRCRESAHA.116.308912.
5
Leaders in Cardiovascular Research: Jeroen Bax.
Cardiovasc Res. 2019 Sep 1;115(11):e109-e110. doi: 10.1093/cvr/cvz125.
6
ATVB Named Lecture Review-Insight Into Author.
Arterioscler Thromb Vasc Biol. 2017 Mar;37(3):381-382. doi: 10.1161/ATV.0000000000000046.
7
Membership spotlight.
Vasc Med. 2017 Jun;22(3):275-277. doi: 10.1177/1358863X17701848.
8
Hiroaki Shimokawa.
Circ Res. 2018 Aug 31;123(6):641-644. doi: 10.1161/CIRCRESAHA.118.313803.
9
ATVB Named Lecture Review-Insight Into Author: Hiroaki Shimokawa.
Arterioscler Thromb Vasc Biol. 2017 May;37(5):780. doi: 10.1161/ATV.0000000000000053.
10
A titan of Cardiovascular Research: Professor Peter Sleight (1929-2020).
Cardiovasc Res. 2021 Apr 23;117(5):e64-e66. doi: 10.1093/cvr/cvab119.
引用本文的文献
1
A novel in vitro model for preclinical testing of the hemocompatibility of intravascular stents according to ISO 10993-4.
J Mater Sci Mater Med. 2011 Jun;22(6):1521-8. doi: 10.1007/s10856-011-4335-2. Epub 2011 May 21.
本文引用的文献
1
Optimal medical therapy with or without PCI for stable coronary disease.
N Engl J Med. 2007 Apr 12;356(15):1503-16. doi: 10.1056/NEJMoa070829. Epub 2007 Mar 26.
2
Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.
N Engl J Med. 2007 Mar 8;356(10):1030-9. doi: 10.1056/NEJMoa067484. Epub 2007 Feb 12.
3
Influence of stent design and material composition on procedure outcome.
J Vasc Surg. 2002 Nov;36(5):1031-9. doi: 10.1067/mva.2002.129113.
4
The trials of an artificial heart.
Sci Am. 2002 Jul;287(1):60-9. doi: 10.1038/scientificamerican0702-60.
5
Nitinol versus stainless steel stents: acute thrombogenicity study in an ex vivo porcine model.
Biomaterials. 2002 Jul;23(14):2997-3005. doi: 10.1016/s0142-9612(02)00030-3.
6
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.
N Engl J Med. 2002 Jun 6;346(23):1773-80. doi: 10.1056/NEJMoa012843.
7
Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up.
Circulation. 2001 Oct 23;104(17):2007-11. doi: 10.1161/hc4201.098056.
8
Pressure rinsing of coronary stents immediately before implantation reduces inflammation and neointimal hyperplasia.
J Am Coll Cardiol. 2001 Aug;38(2):562-8. doi: 10.1016/s0735-1097(01)01394-8.
9
The 2001 Charles T. Dotter lecture: understanding vascular devices at the molecular level is the key to progress.
J Vasc Interv Radiol. 2001 Jul;12(7):789-94. doi: 10.1016/s1051-0443(07)61502-4.
10
Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial.
Circulation. 2001 Jun 12;103(23):2816-21. doi: 10.1161/01.cir.103.23.2816.
Zotero 插件